Assoc. Prof. Dr. Murat Ayhan, MD
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2021Curr Probl Cancer«Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?»· first author
-
2021J Chemother«Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience»· first author
-
2021J Oncol Pharm Pract«Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?»· first author
-
2022EJMI«Value of FDG PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy in locally advanced breast cancer»· first author
-
2022Future Oncol«Real-life data on alectinib treatment in patients with ALK-positive non-small cell lung cancer»· co-author
-
2022J Chemother«Real life data on gastric and gastroesophageal junction cancer treated with neoadjuvant chemotherapy: a Turkish oncology group study»· co-author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.